Incyte secures FDA priority review for pemigatinib in cholangiocarcinoma
Delaware-based pharma company Incyte has secured priority review for pemigatinib from the US Food and Drug Administration (FDA) for the treatment of locally advanced or ... Read More
Y-mAbs begins roll-out of BLA of naxitamab to FDA for neuroblastoma
US biopharma company Y-mAbs Therapeutics has submitted the first portions of its biologics license application (BLA) for naxitamab to the US Food and Drug Administration ... Read More
FDA approves ApiFix MID-C system for progressive AIS
Israeli medical devices manufacturer ApiFix has bagged approval from the US Food and Drug Administration (FDA) for marketing its minimally invasive deformity correction system (MID-C ... Read More
FDA clears Biobeat wearable watch and patch for BP measurement
Israeli biotech company Biobeat has secured a 510A clearance from the US Food and Drug Administration (FDA) for its wearable watch and patch for monitoring ... Read More
Gilead Sciences bags Descovy FDA approval for prevention of HIV infection
Descovy FDA approval : Gilead Sciences’ Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) has been approved by the US Food and ... Read More
AdaptHealth to acquire Patient Care Solutions from McKesson
AdaptHealth, a US home medical equipment provider (HME provider), has agreed to acquire the Patient Care Solutions business from German healthcare and pharma company McKesson. ... Read More
ImmersiveTouch launches ImmersiveView 3.0 VR imaging platform for radiology
ImmersiveTouch, a US medical technology company, has introduced a new virtual reality imaging platform (VR imaging platform) called ImmersiveView 3.0 that enables physicians to combine ... Read More
Innovent Biologics begins phase 1 trial of IBI315 in solid malignancies
Innovent Biologics and Beijing Hanmi Pharmaceutical, a subsidiary of Hanmi Pharmaceutical, said that the first patient has been dosed in a phase 1 clinical trial ... Read More
Global Blood Therapeutics bags Oxbryta FDA approval for sickle cell disease
Oxbryta FDA approval : Global Blood Therapeutics (GBT), a California-based biopharma company, has bagged approval for Oxbryta (voxelotor) tablets from the US Food and Drug ... Read More
Gsport creates cohesive bandages for human and animal patients
Gsport, a Chinese sports medicine company claims to have created high-quality cohesive bandages for human and animal patients. The company, which manufactures therapeutic products in ... Read More